Biotechnology Stocks
| # | Últimos 7 días | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2082 | MESO Mesoblast Limited - American Depositary Shares | 13.74 USD | -3.85% | -3.10% | -3.17% | +31.99% | 1.76 B USD | ||
| 2087 | VIR Vir Biotechnology, Inc. - Common Stock | 10.08 USD | -1.66% | +4.24% | +16.94% | +68.56% | 1.70 B USD | ||
| 2103 | AAPG Ascentage Pharma Group International - American Depository Shar | 18.18 USD | -2.68% | -1.14% | +6.07% | -27.28% | 1.70 B USD | ||
| 2112 | MPLT MapLight Therapeutics, Inc. - Common Stock | 36.52 USD | -1.46% | +2.73% | +22.43% | +92.21% | 1.66 B USD | ||
| 2118 | IMCR Immunocore Holdings plc - American Depositary Shares | 32.95 USD | -1.35% | +3.52% | +16.97% | -1.58% | 1.68 B USD | ||
| 2133 | GHRS GH Research PLC - Ordinary Shares | 26.23 USD | -2.45% | -2.42% | +28.33% | +85.24% | 1.63 B USD | ||
| 2141 | INVA Innoviva, Inc. - Common Stock | 22.37 USD | +0.54% | -0.18% | -0.71% | +25.53% | 1.65 B USD | ||
| 2146 | ABSI Absci Corporation - Common Stock | 10.45 USD | -7.77% | -7.36% | +55.74% | +289.93% | 1.63 B USD | ||
| 2147 | SEPN Septerna, Inc. - Common Stock | 35.90 USD | +0.20% | +5.50% | +16.98% | +63.11% | 1.62 B USD | ||
| 2152 | FTRE Fortrea Holdings Inc. - Common Stock | 17.10 USD | -2.17% | -4.26% | +0.59% | +254.04% | 1.62 B USD | ||
| 2179 | AVBP ArriVent BioPharma, Inc. - Common Stock | 33.00 USD | -3.45% | -4.84% | +6.31% | +60.12% | 1.54 B USD | ||
| 2184 | NVAX Novavax, Inc. - Common Stock | 9.29 USD | -1.80% | -2.21% | +6.17% | +29.75% | 1.53 B USD | ||
| 2187 | XERS Xeris Biopharma Holdings, Inc. - Common Stock | 8.53 USD | -4.59% | +4.28% | +36.48% | +74.80% | 1.47 B USD | ||
| 2203 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 5.70 USD | -3.72% | -8.80% | +12.43% | +103.57% | 1.47 B USD | ||
| 2220 | INBX Inhibrx Biosciences, Inc. - Common Stock | 95.97 USD | -4.74% | -0.55% | +5.46% | +19.10% | 1.41 B USD | ||
| 2232 | MLTX MoonLake Immunotherapeutics - Class A Ordinary Shares | 18.77 USD | -1.98% | -3.35% | +2.62% | +96.34% | 1.38 B USD | ||
| 2237 | IMTX Immatics N.V. - Ordinary Shares | 9.87 USD | -3.80% | -0.30% | +5.00% | -4.64% | 1.32 B USD | ||
| 2259 | MGTX MeiraGTx Holdings plc - Ordinary Shares | 13.95 USD | -4.84% | +6.49% | +53.30% | +59.43% | 1.29 B USD | ||
| 2273 | ARDX Ardelyx, Inc. - Common Stock | 5.34 USD | -0.74% | +1.71% | -5.49% | +18.93% | 1.32 B USD | ||
| 2277 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 15.79 USD | +1.02% | +2.87% | +40.48% | +297.73% | 1.33 B USD |
Noticias Biotechnology Stocks
BofA reitera su calificación de Beam Therapeutics tras fallo arbitral
¿Por qué cae hoy la acción de Beam Therapeutics?
¿Por qué las acciones de Prime Medicine se disparan hoy?
La acción de Incyte alcanza un máximo de 52 semanas en 118,77 dólares
Las acciones de Prime Medicine suben tras ganar arbitraje contra Beam
Resultados de Nurix Therapeutics: la atención se centra en el acuerdo con Roche
Las acciones de Edgewise Therapeutics alcanzan máximos históricos a 43,96 dólares
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |